601 related articles for article (PubMed ID: 22472046)
21. Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.
Di Pietro O; Pérez-Areales FJ; Juárez-Jiménez J; Espargaró A; Clos MV; Pérez B; Lavilla R; Sabaté R; Luque FJ; Muñoz-Torrero D
Eur J Med Chem; 2014 Sep; 84():107-17. PubMed ID: 25016233
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.
Catto M; Berezin AA; Lo Re D; Loizou G; Demetriades M; De Stradis A; Campagna F; Koutentis PA; Carotti A
Eur J Med Chem; 2012 Dec; 58():84-97. PubMed ID: 23108363
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
Li SY; Wang XB; Xie SS; Jiang N; Wang KD; Yao HQ; Sun HB; Kong LY
Eur J Med Chem; 2013 Nov; 69():632-46. PubMed ID: 24095756
[TBL] [Abstract][Full Text] [Related]
24. Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease.
Chen Y; Sun J; Peng S; Liao H; Zhang Y; Lehmann J
Arch Pharm (Weinheim); 2013 Dec; 346(12):865-71. PubMed ID: 24203864
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Li SY; Jiang N; Xie SS; Wang KD; Wang XB; Kong LY
Org Biomol Chem; 2014 Feb; 12(5):801-14. PubMed ID: 24310227
[TBL] [Abstract][Full Text] [Related]
26. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors.
Shi A; Huang L; Lu C; He F; Li X
Bioorg Med Chem; 2011 Apr; 19(7):2298-305. PubMed ID: 21397508
[TBL] [Abstract][Full Text] [Related]
28. Clicked tacrine conjugates as acetylcholinesterase and β-amyloid directed compounds.
Ouberai M; Brannstrom K; Vestling M; Olofsson A; Dumy P; Chierici S; Garcia J
Org Biomol Chem; 2011 Feb; 9(4):1140-7. PubMed ID: 21152577
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
Huang L; Luo Z; He F; Lu J; Li X
Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and evaluation of tacrine-flurbiprofen-nitrate trihybrids as novel anti-Alzheimer's disease agents.
Chen Y; Sun J; Huang Z; Liao H; Peng S; Lehmann J; Zhang Y
Bioorg Med Chem; 2013 May; 21(9):2462-70. PubMed ID: 23541836
[TBL] [Abstract][Full Text] [Related]
31. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.
Benchekroun M; Bartolini M; Egea J; Romero A; Soriano E; Pudlo M; Luzet V; Andrisano V; Jimeno ML; López MG; Wehle S; Gharbi T; Refouvelet B; de Andrés L; Herrera-Arozamena C; Monti B; Bolognesi ML; Rodríguez-Franco MI; Decker M; Marco-Contelles J; Ismaili L
ChemMedChem; 2015 Mar; 10(3):523-39. PubMed ID: 25537267
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Shao D; Zou C; Luo C; Tang X; Li Y
Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease.
Zhang C; Du QY; Chen LD; Wu WH; Liao SY; Yu LH; Liang XT
Eur J Med Chem; 2016 Jun; 116():200-209. PubMed ID: 27061983
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer's Disease.
Fu Y; Mu Y; Lei H; Wang P; Li X; Leng Q; Han L; Qu X; Wang Z; Huang X
Molecules; 2016 Oct; 21(10):. PubMed ID: 27727187
[TBL] [Abstract][Full Text] [Related]
35. Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.
Fernández-Bachiller MI; Pérez C; González-Muñoz GC; Conde S; López MG; Villarroya M; García AG; Rodríguez-Franco MI
J Med Chem; 2010 Jul; 53(13):4927-37. PubMed ID: 20545360
[TBL] [Abstract][Full Text] [Related]
36. New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
Rouleau J; Iorga BI; Guillou C
Eur J Med Chem; 2011 Jun; 46(6):2193-205. PubMed ID: 21435752
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Chen Y; Zhu J; Mo J; Yang H; Jiang X; Lin H; Gu K; Pei Y; Wu L; Tan R; Hou J; Chen J; Lv Y; Bian Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):290-302. PubMed ID: 29278947
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of two different cholinesterases by tacrine.
Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and evaluation of novel 5,6,7-trimethoxyflavone-6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Liao S; Deng H; Huang S; Yang J; Wang S; Yin B; Zheng T; Zhang D; Liu J; Gao G; Ma J; Deng Z
Bioorg Med Chem Lett; 2015 Apr; 25(7):1541-5. PubMed ID: 25724825
[TBL] [Abstract][Full Text] [Related]
40. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
Camps P; Formosa X; Galdeano C; Muñoz-Torrero D; Ramírez L; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Huertas O; Dafni T; Luque FJ
J Med Chem; 2009 Sep; 52(17):5365-79. PubMed ID: 19663388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
